Postmenopausal women who consume aromatase inhibitors develops high risk for cardiova

[News]

Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.

More... (http://www.news-medical.net/news/20101210/Postmenopausal-women-who-consume-aromatase-inhibitors-develops-high-risk-for-cardiovascular-disease.aspx)